Health Canada approves 1st RSV vaccine for people 60 and older

Arexvy

Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over, but it may only be available in "limited" quantities for this fall's respiratory virus season.



Comments

Popular posts from this blog